Initial trials of the potential vaccine could begin in April, but the process of testing and approvals would last at least a year.
The Wall Street Journal, which was first to report the development, said that two doses of the vaccine would be tested on up to 25 volunteers to see if it produces an immune response that protects against the virus. Fauci previously told CNN that researchers could expedite the approval process for a vaccine following a successful Phase 1 trial in an attempt to halt the spread of the virus.
While the experimental vaccine developed by Moderna remains unproven, the speed at which it was created represents a breakthrough.
Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite: